{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:18:33Z","timestamp":1791191913551,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AG037481"],"award-info":[{"award-number":["R01AG037481"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AG037919"],"award-info":[{"award-number":["R01AG037919"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21ES021243"],"award-info":[{"award-number":["R21ES021243"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K01AG044490"],"award-info":[{"award-number":["K01AG044490"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","award":["W81XWH-13-1-0384"],"award-info":[{"award-number":["W81XWH-13-1-0384"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.nbd.2014.05.007","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T22:15:14Z","timestamp":1400364914000},"page":"13-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"special_numbering":"PA","title":["ATP-binding cassette transporter A1: From metabolism to neurodegeneration"],"prefix":"10.1016","volume":"72","author":[{"given":"Radosveta","family":"Koldamova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"Fitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliya","family":"Lefterov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.05.007_bb0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.metabol.2012.11.006","article-title":"The R230C variant of the ATP binding cassette protein A1 (ABCA1) gene is associated with a decreased response to glyburide therapy in patients with type 2 diabetes mellitus","volume":"62","author":"Aguilar-Salinas","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.nbd.2014.05.007_bb0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0026-0495(81)90027-5","article-title":"Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease)","volume":"30","author":"Alaupovic","year":"1981","journal-title":"Metabolism"},{"key":"10.1016\/j.nbd.2014.05.007_bb0015","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1073\/pnas.0500634102","article-title":"Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice","volume":"102","author":"Andersson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.05.007_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2014.05.007_bb0025","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1523\/JNEUROSCI.0033-12.2012","article-title":"Reducing human apolipoprotein E levels attenuates age-dependent Abeta accumulation in mutant human amyloid precursor protein transgenic mice","volume":"32","author":"Bien-Ly","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/eurheartj\/ehs376","article-title":"ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden","volume":"34","author":"Bochem","year":"2013","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.nbd.2014.05.007_bb0035","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1523\/JNEUROSCI.5198-13.2014","article-title":"Reversal of apoE4-driven brain pathology and behavioral deficits by Bexarotene","volume":"34","author":"Boehm-Cagan","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nm1546","article-title":"Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment","volume":"13","author":"Brunham","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2014.05.007_bb0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/ATVBAHA.108.182303","article-title":"Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis","volume":"29","author":"Brunham","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.nbd.2014.05.007_bb0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/pgs.13.18","article-title":"Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease","volume":"14","author":"Cascorbi","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"Pt 2","key":"10.1016\/j.nbd.2014.05.007_bb0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/bj3060599","article-title":"Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E","volume":"306","author":"Castano","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2014.05.007_bb0060","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ajmg.b.30525","article-title":"A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese","volume":"144B","author":"Chu","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.nbd.2014.05.007_bb0065","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI10727","article-title":"Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes","volume":"106","author":"Clee","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2014.05.007_bb0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.05.007_bb0075","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.05.007_bb0080","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/hmg\/dds296","article-title":"Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease","volume":"21","author":"Cruchaga","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2014.05.007_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3233\/JAD-131964","article-title":"Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities","volume":"40","author":"Dias","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.05.007_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.nbd.2014.05.007_bb0095","doi-asserted-by":"crossref","first-page":"34144","DOI":"10.1074\/jbc.M110.108100","article-title":"ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein\/presenilin 1 mice","volume":"285","author":"Donkin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0105","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1523\/JNEUROSCI.1051-10.2010","article-title":"Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice","volume":"30","author":"Fitz","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0115","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","article-title":"Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice","volume":"32","author":"Fitz","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0110","doi-asserted-by":"crossref","first-page":"924-c","DOI":"10.1126\/science.1235809","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Fitz","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.nbd.2014.05.007_bb0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3233\/JAD-132789","article-title":"Improvement of memory deficits and amyloid-beta clearance in aged APP23 mice treated with a combination of anti-amyloid-beta antibody and LXR agonist","volume":"41","author":"Fitz","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.05.007_bb0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2011.04.010","article-title":"Genetic variation in ABCA1 and risk of cardiovascular disease","volume":"218","author":"Frikke-Schmidt","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nbd.2014.05.007_bb0125","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI200420361","article-title":"Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population","volume":"114","author":"Frikke-Schmidt","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2014.05.007_bb0130","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.jacc.2005.06.066","article-title":"Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population","volume":"46","author":"Frikke-Schmidt","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.nbd.2014.05.007_bb0135","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2014.05.007_bb0140","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.0000200082.58536.e1","article-title":"ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I","volume":"26","author":"Gelissen","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.nbd.2014.05.007_bb0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.bbrc.2013.11.059","article-title":"Effects of oxysterols on the blood\u2013brain barrier: implications for Alzheimer's disease","volume":"446","author":"Gosselet","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2014.05.007_bb0150","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1212\/WNL.0b013e318211c352","article-title":"Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging","volume":"76","author":"Gupta","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.05.007_bb0155","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamaneurol.2013.396","article-title":"Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial","volume":"70","author":"Hanson","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2014.05.007_bb0160","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2014.05.007_bb0165","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0175","doi-asserted-by":"crossref","first-page":"41197","DOI":"10.1074\/jbc.M407962200","article-title":"Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain","volume":"279","author":"Hirsch-Reinshagen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0170","doi-asserted-by":"crossref","first-page":"43243","DOI":"10.1074\/jbc.M508781200","article-title":"The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease","volume":"280","author":"Hirsch-Reinshagen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0925-4439(02)00066-2","article-title":"Novel ABCA1 compound variant associated with HDL cholesterol deficiency","volume":"1587","author":"Ho Hong","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.05.007_bb0185","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI8509","article-title":"ABC1: connecting yellow tonsils, neuropathy, and very low HDL","volume":"104","author":"Hobbs","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2014.05.007_bb0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.0954-6820.2003.01256.x","article-title":"HDL deficiency and atherosclerosis: lessons from Tangier disease","volume":"255","author":"Hovingh","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.nbd.2014.05.007_bb0195","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2013.09.040","article-title":"Markers of cholesterol transport are associated with amyloid deposition in the brain","volume":"35","author":"Hughes","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.05.007_bb0205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.05.007_bb0200","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.gene.2012.09.009","article-title":"Meta-analysis on association between the ATP-binding cassette transporter A1 gene (ABCA1) and Alzheimer's disease","volume":"510","author":"Jiang","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.nbd.2014.05.007_bb0210","doi-asserted-by":"crossref","first-page":"e13950","DOI":"10.1371\/journal.pone.0013950","article-title":"Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease","volume":"5","author":"Jones","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2014.05.007_bb0215","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and Abeta in Alzheimer's disease: accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.05.007_bb0220","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1523\/JNEUROSCI.4741-08.2009","article-title":"Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function","volume":"29","author":"Karasinska","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0225","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0091270009335768","article-title":"Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants","volume":"49","author":"Katz","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.nbd.2014.05.007_bb0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/humu.20012","article-title":"Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism","volume":"23","author":"Katzov","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2014.05.007_bb0235","first-page":"256","article-title":"The association between sporadic Alzheimer's disease and the human ABCA1 and APOE gene polymorphisms in Iranian population","volume":"13","author":"Khorram Khorshid","year":"2011","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.nbd.2014.05.007_bb0255","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1074\/jbc.M607831200","article-title":"Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation","volume":"282","author":"Kim","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0240","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1073\/pnas.0711599105","article-title":"Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia","volume":"105","author":"Kim","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.05.007_bb0245","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.05.007_bb0250","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1523\/JNEUROSCI.3773-11.2011","article-title":"Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-beta amyloidosis","volume":"31","author":"Kim","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0260","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","article-title":"Characterization of four lipoprotein classes in human cerebrospinal fluid","volume":"42","author":"Koch","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2014.05.007_bb0280","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1021\/bi002186k","article-title":"Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity","volume":"40","author":"Koldamova","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2014.05.007_bb0275","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.1074\/jbc.M300044200","article-title":"22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion","volume":"278","author":"Koldamova","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0270","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M504513200","article-title":"Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice","volume":"280","author":"Koldamova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0285","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M411420200","article-title":"The liver X receptor ligand T0901317 decreases amyloid {beta} production in vitro and in a mouse model of Alzheimer's disease","volume":"280","author":"Koldamova","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.nbd.2014.05.007_bb0265","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbalip.2010.02.010","article-title":"The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration","volume":"1801","author":"Koldamova","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.05.007_bb0290","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5551\/jat.E599","article-title":"Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations","volume":"16","author":"Koseki","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.nbd.2014.05.007_bb0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0009-8981(97)00207-6","article-title":"Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids","volume":"270","author":"Koudinov","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.nbd.2014.05.007_bb0300","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-8-18","article-title":"Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP\/PS1 mice","volume":"8","author":"LaClair","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2014.05.007_bb0305","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","article-title":"Isoform-specific binding of apolipoprotein E to beta-amyloid","volume":"269","author":"LaDu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0315","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","article-title":"Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid","volume":"270","author":"LaDu","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0310","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbalip.2011.11.005","article-title":"Preferential interactions between ApoE-containing lipoproteins and Abeta revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift","volume":"1821","author":"LaDu","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.05.007_bb0320","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2014.05.007_bb0325","doi-asserted-by":"crossref","DOI":"10.1042\/AN20090015","article-title":"Memory deficits in APP23\/Abca1+\/\u2212 mice correlate with the level of Abeta oligomers","volume":"1","author":"Lefterov","year":"2009","journal-title":"ASN Neuro."},{"key":"10.1016\/j.nbd.2014.05.007_bb0330","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/WNF.0b013e31806450da","article-title":"Bexarotene as add-on to antipsychotic treatment in schizophrenia patients: a pilot open-label trial","volume":"31","author":"Lerner","year":"2008","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2014.05.007_bb0335","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4088\/JCP.12m08160","article-title":"The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial","volume":"74","author":"Lerner","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.nbd.2014.05.007_bb0340","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/dth.12085","article-title":"Oral retinoids and plasma lipids","volume":"26","author":"Lilley","year":"2013","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.nbd.2014.05.007_bb0345","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-90-481-8622-8_7","article-title":"High density lipoprotein structure\u2013function and role in reverse cholesterol transport","volume":"51","author":"Lund-Katz","year":"2010","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0350","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-131121","article-title":"The role of ABCA1 gene sequence variants on risk of Alzheimer's disease","volume":"38","author":"Lupton","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.05.007_bb0355","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","article-title":"Apolipoprotein e sets the stage: response to injury triggers neuropathology","volume":"76","author":"Mahley","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.05.007_bb0360","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.1991.03460010078035","article-title":"Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism","volume":"265","author":"Mahley","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2014.05.007_bb0365","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1021\/cn400100f","article-title":"Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease","volume":"4","author":"McFarland","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0370","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.97.8.4245","article-title":"High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1","volume":"97","author":"McNeish","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.05.007_bb0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0197-4580(99)00103-7","article-title":"Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease","volume":"21","author":"Merched","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.05.007_bb0380","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1220703110","article-title":"ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging","volume":"110","author":"Nagata","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.05.007_bb0385","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.RES.0000250171.54048.5c","article-title":"ATP-binding cassette cholesterol transporters and cardiovascular disease","volume":"99","author":"Oram","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.nbd.2014.05.007_bb0390","doi-asserted-by":"crossref","first-page":"42781","DOI":"10.1074\/jbc.M207601200","article-title":"ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells","volume":"277","author":"Panzenboeck","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0395","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/8904_2011_81","article-title":"A non-classical presentation of Tangier disease with three ABCA1 mutations","volume":"4","author":"Pervaiz","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.nbd.2014.05.007_bb0400","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.277.5332.1684","article-title":"Synaptic efficacy enhanced by glial cells in vitro","volume":"277","author":"Pfrieger","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.05.007_bb0405","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain","volume":"262","author":"Pitas","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0410","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer's disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2014.05.007_bb0415","doi-asserted-by":"crossref","first-page":"924-d","DOI":"10.1126\/science.1234089","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Price","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.05.007_bb0420","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF03261839","article-title":"Tangier disease: epidemiology, pathophysiology, and management","volume":"12","author":"Puntoni","year":"2012","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.nbd.2014.05.007_bb0425","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1210\/jc.2012-2185","article-title":"Approach to the patient with extremely low HDL-cholesterol","volume":"97","author":"Rader","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2014.05.007_bb0430","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","article-title":"Associations between serum cholesterol levels and cerebral amyloidosis","volume":"71","author":"Reed","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2014.05.007_bb0435","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11883-012-0307-3","article-title":"Dyslipidemia and the risk of Alzheimer's disease","volume":"15","author":"Reitz","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.nbd.2014.05.007_bb0440","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/humu.21076","article-title":"A survey of ABCA1 sequence variation confirms association with dementia","volume":"30","author":"Reynolds","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2014.05.007_bb0445","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mcn.2007.01.011","article-title":"The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease","volume":"34","author":"Riddell","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0450","doi-asserted-by":"crossref","first-page":"e79771","DOI":"10.1371\/journal.pone.0079771","article-title":"Alzheimer's disease: analyzing the missing heritability","volume":"8","author":"Ridge","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2014.05.007_bb0455","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ajmg.b.30552","article-title":"Association of genetic variants of ABCA1 with Alzheimer's disease risk","volume":"144B","author":"Rodriguez-Rodriguez","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.nbd.2014.05.007_bb0460","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-2012-112090","article-title":"Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-beta peptide accumulation","volume":"30","author":"Saint-Pol","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.05.007_bb0465","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0022-2275(20)30266-2","article-title":"Regulation and intracellular trafficking of the ABCA1 transporter","volume":"42","author":"Santamarina-Fojo","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2014.05.007_bb0470","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/01.STR.24.9.1416","article-title":"Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease","volume":"24","author":"Saunders","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.nbd.2014.05.007_bb0475","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.2337\/dc12-0082","article-title":"ABC transporter genes and risk of type 2 diabetes: a study of 40,000 individuals from the general population","volume":"35","author":"Schou","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nbd.2014.05.007_bb0480","doi-asserted-by":"crossref","first-page":"e1004147","DOI":"10.1371\/journal.pgen.1004147","article-title":"Re-sequencing expands our understanding of the phenotypic impact of variants at GWAS loci","volume":"10","author":"Service","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2014.05.007_bb0485","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-122425","article-title":"Plasma amyloid-beta in patients with Tangier disease","volume":"35","author":"Shahim","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.05.007_bb0490","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2005.08.048","article-title":"Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease","volume":"391","author":"Shibata","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.05.007_bb0495","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.05.007_bb0500","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1093\/hmg\/ddr358","article-title":"A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci","volume":"20","author":"Singleton","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.05.007_bb0505","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.05.007_bb0510","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/JGP.0b013e3182423b6a","article-title":"The polymorphism of the ATP-binding cassette transporter 1 gene modulates Alzheimer disease risk in Chinese Han ethnic population","volume":"20","author":"Sun","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.nbd.2014.05.007_bb0515","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.neurobiolaging.2006.04.005","article-title":"Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease","volume":"28","author":"Sundar","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.05.007_bb0520","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-9-2","article-title":"Soluble apoE\/Abeta complex: mechanism and therapeutic target for APOE4-induced AD risk","volume":"9","author":"Tai","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2014.05.007_bb0525","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbalip.2009.03.011","article-title":"The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes","volume":"1791","author":"Tang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.05.007_bb0530","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1523\/JNEUROSCI.6546-10.2011","article-title":"Critical role of astroglial apolipoprotein E and liver X receptor-alpha expression for microglial Abeta phagocytosis","volume":"31","author":"Terwel","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0535","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.05.007_bb0540","doi-asserted-by":"crossref","first-page":"924-e","DOI":"10.1126\/science.1233937","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Tesseur","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.05.007_bb0545","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1172\/JCI200523915","article-title":"Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I","volume":"115","author":"Timmins","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2014.05.007_bb0550","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/me.2003-0061","article-title":"Liver X receptor signaling pathways in cardiovascular disease","volume":"17","author":"Tontonoz","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.nbd.2014.05.007_bb0555","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(02)07277-X","article-title":"Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study","volume":"359","author":"van Dam","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2014.05.007_bb0560","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.neurobiolaging.2009.07.005","article-title":"Liver X receptor activation restores memory in aged AD mice without reducing amyloid","volume":"32","author":"Vanmierlo","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.05.007_bb0565","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1194\/jlr.M300078-JLR200","article-title":"ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions","volume":"44","author":"Vaughan","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2014.05.007_bb0570","doi-asserted-by":"crossref","first-page":"25123","DOI":"10.1074\/jbc.M704590200","article-title":"Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles","volume":"282","author":"Vedhachalam","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0575","doi-asserted-by":"crossref","first-page":"924-f","DOI":"10.1126\/science.1235505","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Veeraraghavalu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.05.007_bb0580","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2337\/dc09-1562","article-title":"Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction","volume":"33","author":"Vergeer","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nbd.2014.05.007_bb0585","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.05.007_bb0590","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2337\/db07-0484","article-title":"Association of the ATP-binding cassette transporter A1 R230C variant with early-onset type 2 diabetes in a Mexican population","volume":"57","author":"Villarreal-Molina","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2014.05.007_bb0610","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","article-title":"ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE","volume":"279","author":"Wahrle","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0595","doi-asserted-by":"crossref","first-page":"43236","DOI":"10.1074\/jbc.M508780200","article-title":"Deletion of Abca1 increases A{beta} deposition in the PDAPP transgenic mouse model of Alzheimer disease","volume":"280","author":"Wahrle","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.05.007_bb0615","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-2-7","article-title":"Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms","volume":"2","author":"Wahrle","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2014.05.007_bb0600","first-page":"671","article-title":"Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease","volume":"118","author":"Wahrle","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2014.05.007_bb0620","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1006\/bbrc.1994.2742","article-title":"The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects","volume":"205","author":"Walter","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2014.05.007_bb0625","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0021-9150(94)90205-4","article-title":"Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency","volume":"110","author":"Walter","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nbd.2014.05.007_bb0630","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2007.02.005","article-title":"Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese","volume":"1147","author":"Wang","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.05.007_bb0635","doi-asserted-by":"crossref","first-page":"13878","DOI":"10.1073\/pnas.172510899","article-title":"Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration","volume":"99","author":"Wang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.05.007_bb0640","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.05.007_bb0645","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s11033-012-2115-9","article-title":"Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease","volume":"40","author":"Wang","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.nbd.2014.05.007_bb0650","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neulet.2007.02.010","article-title":"ABCA1 polymorphisms and Alzheimer's disease","volume":"416","author":"Wavrant-De Vrieze","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.05.007_bb0655","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.114.300738","article-title":"ATP-binding cassette transporters, atherosclerosis, and inflammation","volume":"114","author":"Westerterp","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.nbd.2014.05.007_bb0660","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2014.05.007_bb0665","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/bbrc.1993.1423","article-title":"Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid","volume":"192","author":"Wisniewski","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2014.05.007_bb0670","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0197-4580(02)00094-5","article-title":"ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease","volume":"24","author":"Wollmer","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.05.007_bb0675","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1074-5521(96)90183-0","article-title":"An ApoE-Abeta inhibition complex in Abeta fibril extension","volume":"3","author":"Wood","year":"1996","journal-title":"Chem. Biol."},{"key":"10.1016\/j.nbd.2014.05.007_bb0680","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1021\/bi961074j","article-title":"Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E","volume":"35","author":"Wood","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2014.05.007_bb0685","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1476-511X-11-163","article-title":"Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease","volume":"11","author":"Xiao","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.nbd.2014.05.007_bb0690","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1523\/JNEUROSCI.1569-12.2012","article-title":"PPARgamma\/RXRalpha-induced and CD36-mediated microglial amyloid-beta phagocytosis results in cognitive improvement in amyloid precursor protein\/presenilin 1 mice","volume":"32","author":"Yamanaka","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.05.007_bb0695","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bbalip.2010.05.001","article-title":"Proposed mechanism for lipoprotein remodelling in the brain","volume":"1801","author":"Yu","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.05.007_bb0700","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1073\/pnas.0701096104","article-title":"Attenuation of neuroinflammation and Alzheimer's disease pathology by liver X receptors","volume":"104","author":"Zelcer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114001259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114001259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T19:24:50Z","timestamp":1649013890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114001259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":139,"alternative-id":["S0969996114001259"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.05.007","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATP-binding cassette transporter A1: From metabolism to neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}